In vitro diagnostics to be included in FDA guidance covering the controversial "least burdensome" clause
This article was originally published in Clinica
Executive Summary
The US FDA has decided to include in vitro diagnostics in future drafts of its guidance on how to implement the "least burdensome" provision of the FDA Modernization Act (FDAMA) of 1997.